Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
Is a |
Product containing dihydrocodeine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opiate agonist (substance) |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydrocodeine (substance) |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opioid receptor agonist |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydrocodeine tartrate |
false |
Inferred relationship |
Some |
|
|
tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|